International Journal of Nanomedicine-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-09-04 14503317m86暂无昵称来自湖北省

偏重的研究方向：纳米材料;生物材料;纳米医学
经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-09-09 14503317m86暂无昵称来自湖北省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：纳米材料;纳米医学
经验分享：为什么最近这么慢啊

25 0

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-02-17 ms4000000682446173

请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件

93 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-03-16 ms1000001348559113 来自天津

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：药物递送;纳米技术
经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？

37 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-06-27 ms7000001729802382 来自广西

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：纳米颗粒
经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。

36 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2023-07-03 ms7000000697984123 来自贵州省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：纳米材料;自噬;肿瘤
经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？

27 0

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-07-22 ms3000000979708654

2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？

35 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2020-01-17 sugdcbbc

审稿速度:2.0 | 投稿命中率:50.0
经验分享：请问状态3B：accept with changes是修改后接受么？

187 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2020-01-17 ms1875852553058278

审稿速度:2.0
经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章

140 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2156022, encodeId=5978215602236, content=偏重的研究方向：纳米材料;生物材料;纳米医学 经验分享：难。4C快一个月了没动静。打开官网一看主编都换了。文章接收会不会有影响啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Mon Sep 04 13:44:01 CST 2023, time=2023-09-04, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2156821, encodeId=00d52156821bd, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;纳米医学 经验分享：为什么最近这么慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=fd974904405, createdName=14503317m86暂无昵称, createdTime=Sat Sep 09 01:44:15 CST 2023, time=2023-09-09, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1194376, encodeId=79e811943e668, content=请问大家3B - REPORT: REVISE WITH CHANGES后多久会收到修改意见的邮件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=022a5419460, createdName=ms4000000682446173, createdTime=Thu Feb 17 10:44:22 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2119882, encodeId=5f06211988285, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：药物递送;纳米技术 经验分享：从投稿到接收两个月零四天，现在到了5B阶段，想问下付完钱多久能刊出？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ce7c8434004, createdName=ms1000001348559113, createdTime=Thu Mar 16 08:48:44 CST 2023, time=2023-03-16, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2145062, encodeId=05d621450623f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米颗粒 经验分享：大家在Sent to Editor-in-Chief for acceptance or rejection进入了4CR - PEER REVIEWER(S) SECOND ROUND过么？这是又要开始第二轮么。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=57ba5724859, createdName=ms7000001729802382, createdTime=Tue Jun 27 18:30:23 CST 2023, time=2023-06-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=2146109, encodeId=ef7121461091f, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：纳米材料;自噬;肿瘤 经验分享：这个期刊的WB原始数据提时必须是完整的膜吗？转膜剪裁后才曝光的是不是不行了？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=993b6484739, createdName=ms7000000697984123, createdTime=Mon Jul 03 15:35:15 CST 2023, time=2023-07-03, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=1234013, encodeId=0a19123401365, content=2G状态提示评审意见发送给主编了，现在已经2周了，不知道什么情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50135526541, createdName=ms3000000979708654, createdTime=Fri Jul 22 13:47:56 CST 2022, time=2022-07-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=583551, encodeId=297b58355121, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：请问状态3B：accept with changes是修改后接受么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=ae4f2132258, createdName=sugdcbbc, createdTime=Fri Jan 17 00:00:00 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856920, encodeId=10e485692007, content=审稿速度:2.0 经验分享：12.4号投稿，12.23一审意见修回，2月份编辑还不把意见发给我，每次询问都是官方回复，回复的编辑跟审稿的编辑还不是同一个人，我天天催，催着编辑帮我询问审稿编辑，还是没有结果。据说有的内容有创新性的两个月就能接收，像我们这种编辑拖着不回复的都是他们不重视的文章 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=140, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a4765414076, createdName=ms1875852553058278, createdTime=Fri Jan 17 11:42:53 CST 2020, time=2020-01-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2101182, encodeId=b37d210118265, content=投稿命中率:50.0 偏重的研究方向：外泌体 经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2bea5414925, createdName=ms1000001212608631, createdTime=Thu Nov 17 19:24:54 CST 2022, time=2022-11-17, status=1, ipAttribution=)]

2022-11-17 ms1000001212608631

投稿命中率:50.0
偏重的研究方向：外泌体
经验分享：11.4投稿 11.15显示寻找审稿人，邮件要求上传wb原始图。当天上传裁过的wb图，手动标记marker。 11.16因为图片原因拒稿。整体其实没那么简单，拒稿还是很快

29 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务